Dr. Michael Severino is Vice Chairman and President, responsible for research and development and the corporate strategy office. He previously served as Executive Vice President, Research & Development and Chief Scientific Officer of AbbVie.
Prior to joining AbbVie in 2014, Dr. Severino was Senior Vice President, Global Development and Chief Medical Officer at Amgen, Inc. During his time at Amgen, he served in roles of increasing responsibility across a broad range of therapeutic areas including oncology, inflammation, neuroscience, cardiovascular and metabolic disorders.
Dr. Severino serves on the Board of Directors for Avantor and the Board of Trustees for the Field Museum. At AbbVie, he is the executive chair of the Black Business Network Employee Resource Group.
He earned a bachelor’s degree in biochemistry from the University of Maryland, College Park and a doctorate in medicine from The Johns Hopkins University in Baltimore, Maryland, U.S.A. Dr. Severino completed his residency and fellowship training at the Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts, U.S.A.
What is Michael Severino's net worth?
The estimated net worth of Michael Severino is at least $23.85 million as of May 23rd, 2022. Dr. Severino owns 152,103 shares of AbbVie stock worth more than $23,845,187 as of March 22nd. This net worth evaluation does not reflect any other assets that Dr. Severino may own. Learn More about Michael Severino's net worth.
How do I contact Michael Severino?
Has Michael Severino been buying or selling shares of AbbVie?
Michael Severino has not been actively trading shares of AbbVie during the last ninety days. Most recently, Michael Severino sold 79,801 shares of the business's stock in a transaction on Monday, May 23rd. The shares were sold at an average price of $150.90, for a transaction totalling $12,041,970.90. Following the completion of the sale, the insider now directly owns 152,103 shares of the company's stock, valued at $22,952,342.70. Learn More on Michael Severino's trading history.
Who are AbbVie's active insiders?
AbbVie's insider roster includes Carlos Alban (Vice Chairman), Roxanne Austin (Director), Nicholas Donoghoe (SVP), Brian Durkin (VP), Richard Gonzalez (CEO), Henry Gosebruch (EVP), Robert Michael (Vice Chairman), Scott Reents (Sr. VP & CFO ), Timothy Richmond (EVP), Azita Saleki-Gerhardt (EVP), Laura Schumacher (Vice Chairman), Michael Severino (Vice Chairman), Elaine Sorg (SVP), Jeffrey Stewart (EVP), and Carrie Strom (SVP). Learn More on AbbVie's active insiders.
Are insiders buying or selling shares of AbbVie?
During the last year, insiders at the sold shares 14 times. They sold a total of 693,567 shares worth more than $106,210,421.50. The most recent insider tranaction occured on March, 13th when EVP Jeffrey Ryan Stewart sold 53,125 shares worth more than $8,089,875.00. Insiders at AbbVie own 0.1% of the company.
Learn More about insider trades at AbbVie. Information on this page was last updated on 3/13/2023.
